Question

As therapy for sleep disorders, which one of the following classes of medication should be discouraged in the long-term care setting due to risk of adverse effects (e.g., memory impairment, falls, daytime sleepiness), physiologic tolerance, and adverse effects of discontinuation?

A. Tricyclic antidepressants
B. Antipsychotics
C. Serotonergic antidepressants
D. Non-benzodiazepine sedative hypnotics
E. Benzodiazepines

Answer 1

Benzodiazepines should be discouraged in the long-term care setting for therapy of sleep disorders due to adverse effects and risk of dependence and tolerance.

Step-by-step explanation:

The class of medication that should be discouraged in the long-term care setting for therapy of sleep disorders due to risk of adverse effects such as memory impairment, falls, and daytime sleepiness, as well as physiologic tolerance and adverse effects of discontinuation, is E. Benzodiazepines. Benzodiazepines are known to cause cognitive and behavioral adverse effects, and there is a risk of dependence and tolerance with prolonged use. It is important to carefully consider the potential risks and benefits when prescribing medication for sleep disorders.